Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. announced an update on its share buyback program, initiated on April 30, 2025, to support stock option and performance share plans. The company purchased 28,096 ordinary shares between September 29 and October 3, 2025, at an average price of €51.0925 per share. As of October 3, 2025, Recordati held 4,552,651 own shares, representing 2.177% of its share capital. This buyback program is part of Recordati’s strategy to enhance shareholder value and support its incentive plans, reflecting its commitment to long-term growth and stability.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR58.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. Originating in the 1920s from a family-run pharmacy in Northern Italy, the company provides therapeutic options in both general and specialist medicine, as well as for rare diseases. Recordati operates in a fully integrated manner, covering clinical development, production, marketing, and licensing of active ingredients and finished products. It is present in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people worldwide.
Average Trading Volume: 235,181
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11.03B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.